Speaker illustration

Professor Lawrence Leiter

University of Toronto, Toronto (Canada)

Member of:

European Society of Cardiology

A cross-specialty focus – Who are the appropriate patients for SGLT2is?

Event: ESC Congress 2019

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?

Event: ESC Congress 2019

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

Thumbnail

GLP-1 Receptor agonists – Pioneers of further cardiovascular risk reduction in diabetes?

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

The future of SGLT2 Inhibitor Cardiovascular Outcomes trials: what are we hoping to learn?

Event: ESC Congress 2018

Topic: Pharmacology and Pharmacotherapy

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

Clinical considerations for cardiologists: exploring the evidence for primary and secondary prevention in type 2 diabetes

Event: ESC Congress 2016

Topic: Diabetes management

Session type: Satellite Symposium

Thumbnail